1. This document discusses the treatment and management of hepatitis B in Taiwan. It provides guidelines for the treatment of hepatitis B based on disease severity and stage. 2. The guidelines outline 9 treatment criteria based on factors like HBeAg status, ALT levels, liver stiffness measurements, and genotype. First-line treatments recommended are pegylated interferon-alfa or nucleoside analogues like entecavir and tenofovir. 3. The guidelines aim to help eradicate hepatitis B in Taiwan through effective disease management and treatment according to the criteria provided. Regular monitoring of disease markers and liver function is important to determine treatment response and progression.